Product
TQH2929
2 clinical trials
2 indications
Indication
PsoriasisIndication
Generalized Pustular PsoriasisClinical trial
Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Profile, and Efficacy of TQH2929 in Healthy Adult SubjectsStatus: Recruiting, Estimated PCD: 2025-01-01
Clinical trial
Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Profile, and Efficacy of TQH2929 in Healthy Adult Subjects and Psoriasis SubjectsStatus: Not yet recruiting, Estimated PCD: 2025-02-01